FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The peptide with big claims and scant evidence STAT Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Think twice before injecting peptides bought online: unauthorized products can seriously harm you Canada.ca BioCentury RFK Jr.'s peptide deregulation threatens the foundations of drug safety